Clinical Trials Directory

Trials / Completed

CompletedNCT01268007

Heartbeat Sensitivity Calibration Using the ECG Accessory

This is an Observational, Un-blinded, Non-significant Risk, Non-interventional Study Designed to Collect ECG Data on at Least One Subject Out of a Pool of up to Three (3) Healthy Male Subjects at One Clinical Site (Clinical Trials of Texas).

Status
Completed
Phase
Study type
Observational
Enrollment
1 (estimated)
Sponsor
Cyberonics, Inc. · Industry
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is an observational, un-blinded, non-significant risk, non-interventional study designed to collect ECG data on at least one subject out of a pool of up to three (3) healthy male subjects at one clinical site (Clinical Trials of Texas). Cyberonics will be collecting ECG recordings collected by an investigational device for comparison with conventional ECG recordings. This data will be used to validate a new device under development.

Detailed description

This is an observational, un-blinded, non-significant risk, non-interventional study designed to collect ECG data on at least one subject out of a pool of up to three (3) healthy male subjects at one clinical site (Clinical Trials of Texas). If acceptable data is acquired from one (1) subject the remaining subjects will not be entered into the study. Three (3) to six (6) researchers will record data, but all direct contact with the subject will be done by the study coordinator or principal investigator (PI). The purpose of this study is to validate a Heartbeat Sensitivity calibration process utilizing the Cyberonics ECG Accessory. The non-invasive, passive collection of ECG signals from a resting healthy subject will be used to validate the use of the ECG Accessory with the Model 201 Programming Wand, Model 250 VNS Programming Software Version 9.0, Model 106 Generator, and ECG monitor (DRE True ECG-12), as well as the associated Instructions for Use. The data generated from this exercise will be used in future clinical trials utilizing this device.

Conditions

Timeline

Start date
2010-12-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2010-12-29
Last updated
2011-01-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01268007. Inclusion in this directory is not an endorsement.